Physician profile
Jonathan E Bullock
NPI 1932617743
$3,759.94
in general payments reported to CMS, 2019-2025
24 companies · $728 in 2025
The $728 reported for 2025 was more than what 78% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $684 · 2022: $661 · 2023: $940 · 2024: $747 · 2025: $728.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,415.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,414.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $1,008.48 | 2021-2024 | Xarelto |
| Inari Medical, INC. | $514.22 | 2022-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Abbvie INC. | $400.55 | 2021-2023 | |
| Merck Sharp & Dohme LLC | $395.34 | 2021-2025 | Zerbaxa, Dificid, Recarbrio |
| Recor Medical INC | $210.11 | 2024-2025 | Paradise Ultrasound Renal Denervation System, Paradise Renal Denervation System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $178.60 | 2022-2024 | Lifevest |
| Solventum Corporation | $159.84 | 2025 | V.A.C. Veraflo, Prevena |
| Bayer Healthcare Pharmaceuticals INC. | $124.99 | 2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $118.52 | 2021-2025 | Xifaxan |
| Alexion Pharmaceuticals, INC. | $116.90 | 2023-2025 | Ultomiris |
| E.R. Squibb & Sons, L.L.C. | $112.36 | 2021-2023 | Camzyos |
| Gilead Sciences, INC. | $83.24 | 2021-2024 | Veklury |
| Insmed, INC. | $57.36 | 2025 | Arikayce |
| Smith+Nephew, INC. | $51.53 | 2022 | |
| Astrazeneca Pharmaceuticals Lp | $35.19 | 2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $31.90 | 2023 | Jardiance |
| Janssen Scientific Affairs, LLC | $30.36 | 2023 | Xarelto |
| Stryker Corporation | $23.51 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Melinta Therapeutics, LLC | $23.17 | 2024 | Rezzayo, Vabomere, Orbactiv |
| Genentech USA, INC. | $18.64 | 2025 | Tnkase |
| Amgen INC. | $18.58 | 2024 | |
| Urgo Medical North America, LLC | $16.06 | 2024 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Bioxcel Therapeutics, INC. | $15.73 | 2023 | Igalmi |
| Mallinckrodt Hospital Products INC. | $14.76 | 2025 | Terlivaz |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Bullock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.